Published in J Thorac Oncol on February 01, 2015
Role for adjuvant chemotherapy in patients with resected small cell lung cancer. J Thorac Dis (2016) 0.75
Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience. J Thorac Dis (2017) 0.75
Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis. Lung (2016) 0.75
Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis. J Thorac Dis (2017) 0.75
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
The new lung cancer staging system. Chest (2009) 6.30
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med (2007) 3.39
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol (2010) 1.96
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol (2012) 1.84
Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest (2012) 1.60
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol (2004) 1.56
Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg (2007) 1.54
"Back to the future": recruiting the best and brightest into cardiothoracic surgery. J Thorac Cardiovasc Surg (2010) 1.53
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer J (2007) 1.46
Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37
The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol (2015) 1.20
Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol (2011) 1.16
Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12
An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 1.08
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol (2009) 1.08
New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther (2009) 1.07
Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg (2008) 1.06
Update on cardiothoracic surgery resident job opportunities. Ann Thorac Surg (2010) 1.04
Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer (2012) 1.04
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2009) 1.03
Lumping, splitting, and sorting. J Thorac Oncol (2007) 1.01
Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res (2010) 1.01
Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol (2009) 1.01
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
Bilateral intrathoracic kidneys and adrenal glands associated with posterior congenital diaphragmatic hernias. Ann Thorac Surg (2008) 0.98
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg (2013) 0.98
The effect of a lung cancer care coordination program on timeliness of care. Clin Lung Cancer (2013) 0.98
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 0.98
Psoas muscle metastases in non-small cell lung cancer. J Thorac Dis (2012) 0.97
Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg (2007) 0.97
Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg (2011) 0.95
A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage. J Thorac Oncol (2010) 0.95
Multifocal right atrial myxoma and pulmonary embolism. Ann Thorac Surg (2003) 0.95
Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol (2015) 0.94
Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg (2003) 0.94
Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary? Ann Thorac Surg (2004) 0.94
A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res (2013) 0.93
Roux-en-Y duodenojejunostomy in the treatment of Bouveret syndrome. South Med J (2009) 0.92
Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92
Central pancreatectomy for a pancreatic ganglioneuroma in a patient with previous neuroblastoma. Pancreatology (2002) 0.92
Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer (2012) 0.91
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.91
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS). Support Care Cancer (2008) 0.90
Looking in from above and up from below: new vistas in thoracic surgery. Innovations (Phila) (2012) 0.90
Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90
Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.90
Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. Cancer (2011) 0.90
Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89
In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation. J Biol Chem (2006) 0.89
The fable of Babel and building a foundation for quality. J Thorac Oncol (2012) 0.89
A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol (2014) 0.89
Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest (2013) 0.89
Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. J Clin Oncol (2008) 0.89
Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg (2003) 0.87
Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys (2012) 0.87
Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg (2013) 0.87
Right middle lobectomy for a primary pulmonary leiomyoma: a case report. Cases J (2009) 0.87
Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol (2009) 0.86
Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival. J Clin Oncol (2007) 0.86
Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg (2013) 0.85
Screening for lung cancer: moving into a new era. Ann Intern Med (2013) 0.85